The Point behind Translation of Aptamers for Point of Care Diagnostics
The Point behind Translation of Aptamers for Point of Care Diagnostics
Tarun Kumar Sharma, John G. Bruno and William C. Cho
ABSTRACT
Owing to the high affinity and specificity in recent years aptamers, have emerged as competitive tools with the potential to replace antibodies in many diagnostic formats. The aptamer industry is continuously growing to create space in research and diagnostics markets. However, translation of aptamer in several applied disciplines is still lagging behind as compared to antibodies. In this article, we discuss the translational aspects of aptamers, current potential of aptamers and strategies to create the “bench-to-bedside” translation of aptamer technology.
To share on other social networks, click on any share button. What are these?
